Markus J. Riemenschneider

Improved discrimination of AD patients using β-amyloid _(1-42) and tau levels in CSF

Frank Hulstaert, Kaj Blennow, Adrian Ivanoiu et al. · Neurology · 1999 · 732 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +17

Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials

Daphne W. Bell, Thomas J. Lynch, Sara M. Haserlat et al. · Journal of Clinical Oncology · 2005 · 607 citations

Medicine, Molecular Genetics, Oncology +17

Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson’s Disease

Annika Sommer, Franz Marxreiter, Florian Krach et al. · Cell stem cell · 2018 · 348 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Effect of<i>APOE</i>genotype on amyloid plaque load and gray matter volume in Alzheimer disease

Alexander Drzezga, Timo Grimmer, G. Henriksen et al. · Neurology · 2009 · 251 citations

Medicine, Neurology, Neuroscience +17

Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.

Markus J. Riemenschneider, Rainer Büschges, Marietta Wolter et al. · PubMed · 1999 · 249 citations

Medicine, Molecular Genetics, Oncology +14